#pancreatic cancer

Triple Combo for Pancreatic Cancer

TRK inhibitor larotrectinib led to durable responses in people with colon, pancreatic, appendix, bile duct and liver cancers.

Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.

Gastrointestinal cancers conference emphasizes patient quality of life.

The Supreme Court justice recently underwent treatment for pancreatic cancer.

“I have never faced a fight quite like the one I have now,” he says.

PARP inhibitor delays disease progression when used after successful chemotherapy.

New site-agnostic therapies highlight the importance of genetic testing.

The bottom line is that people risk not having their genetic alterations identified if they do not have genetic consultations.

Jean Trebek, a practitioner of Religious Science, uses healing sound, Reiki touch and walking meditation to stay positive.

November is National Pancreatic Cancer Awareness Month.

What to eat during pancreatic cancer treatment and common side effects

Zenocutuzumab targets tumors with a specific genetic alteration, making it potentially active against cancer at multiple locations.

A study in mice suggests that therapies approved for breast cancer may also combat other types, including colorectal and stomach cancer.

Lynparza maintenance therapy after chemotherapy nearly doubled progression-free survival.

The test was able to identify many cancers, and their location, at early stages.